Purpose: To determine the presenting characteristics of patients with neovascular age-related macular degeneration with long-term remission (LTR), which was defined as the absence of intraretinal/subretinal fluid, or hemorrhage, and absence of leakage on fluorescein angiography for longer than 6 months while on as-needed antivascular endothelial growth factor treatment. Methods: The presenting characteristics of patients with LTR were compared with a control group including 32 eyes of 28 age-, gender-, and ethnicity-matched patients who did not achieve LTR. Results: Seventy-four percent of patients in the LTR group had Type 1 choroidal neovascular membrane and 18.5% had retinal angiomatous proliferation. In the control group, 28 eyes had Type 1 choroidal neovascular membrane (87.5%), and none of the patients had retinal angiomatous proliferation; overall, there was a significant difference in lesion types between the 2 groups (P = 0.036). Eyes with LTR at presentation had significantly thinner subfoveal choroidal thickness (147 vs. 178 mu m, P = 0.04). There was more intraretinal fluid and less subretinal fluid at the presentation in the remission group (59.3% intraretinal fluid and 11.1% subretinal fluid) compared with the control group (28.1% intraretinal fluid and 34.4% subretinal fluid, P = 0.03). Conclusion: The presence of retinal angiomatous proliferation, thinner choroidal thickness, more intraretinal fluid, and less subretinal fluid at presentation were associated with LTR in patients receiving as-needed treatment for age-related macular degeneration.
基金:
UCSD Vision Research Center Core Grant [P30EY022589]; Research to Prevent Blindness, NYResearch to Prevent Blindness (RPB); ICO-Retina Research Foundation Helmerich Fellowship; Beijing Talents Fund [2015000021223ZK22]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81400422]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY022589] Funding Source: NIH RePORTER
第一作者机构:[1]Univ Calif San Diego, Shiley Eye Inst, Dept Ophthalmol, Jacobs Retina Ctr, San Diego, CA 92103 USA
通讯作者:
通讯机构:[1]Univ Calif San Diego, Shiley Eye Inst, Dept Ophthalmol, Jacobs Retina Ctr, San Diego, CA 92103 USA[*1]9415 Campus Point Dr 0946, La Jolla, CA 92093 USA
推荐引用方式(GB/T 7714):
Muftuoglu Ilkay Kilic,Alam Mostafa,You Qi Sheng,et al.LONG-TERM REMISSION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH AS-NEEDED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY[J].RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES.2018,38(3):516-522.doi:10.1097/IAE.0000000000001572.
APA:
Muftuoglu, Ilkay Kilic,Alam, Mostafa,You, Qi Sheng,Gaber, Raouf,Ramkumar, Hema L....&Freeman, William R..(2018).LONG-TERM REMISSION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH AS-NEEDED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,38,(3)
MLA:
Muftuoglu, Ilkay Kilic,et al."LONG-TERM REMISSION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH AS-NEEDED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY".RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES 38..3(2018):516-522